231 related articles for article (PubMed ID: 16282299)
1. The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration.
de Rochars MB; Kanjilal S; Direny AN; Radday J; Lafontant JG; Mathieu E; Rheingans RD; Haddix AC; Streit TG; Beach MJ; Addiss DG; Lammie PJ
Am J Trop Med Hyg; 2005 Nov; 73(5):888-94. PubMed ID: 16282299
[TBL] [Abstract][Full Text] [Related]
2. Endpoints for lymphatic filariasis programs.
Grady CA; de Rochars MB; Direny AN; Orelus JN; Wendt J; Radday J; Mathieu E; Roberts JM; Streit TG; Addiss DG; Lammie PJ
Emerg Infect Dis; 2007 Apr; 13(4):608-10. PubMed ID: 17553278
[TBL] [Abstract][Full Text] [Related]
3. Improving community participation to eliminate lymphatic filariasis in American Samoa.
King JD; Zielinski-Gutierrez E; Pa'au M; Lammie P
Acta Trop; 2011 Sep; 120 Suppl 1():S48-54. PubMed ID: 20932818
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
[TBL] [Abstract][Full Text] [Related]
5. Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.
Modi A; Gamit S; Jesalpura BS; Kurien G; Kosambiya JK
PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005476. PubMed ID: 28369129
[TBL] [Abstract][Full Text] [Related]
6. Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India.
Ramaiah KD; Vanamail P; Yuvaraj J; Das PK
Trans R Soc Trop Med Hyg; 2011 Aug; 105(8):431-7. PubMed ID: 21601901
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach.
Fraser M; Taleo G; Taleo F; Yaviong J; Amos M; Babu M; Kalkoa M
Am J Trop Med Hyg; 2005 Oct; 73(4):753-8. PubMed ID: 16222021
[TBL] [Abstract][Full Text] [Related]
8. Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000.
McLaughlin SI; Radday J; Michel MC; Addiss DG; Beach MJ; Lammie PJ; Lammie J; Rheingans R; Lafontant J
Am J Trop Med Hyg; 2003 May; 68(5):568-73. PubMed ID: 12812348
[TBL] [Abstract][Full Text] [Related]
9. Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations.
Sunish IP; Munirathinam A; Kalimuthu M; Ashok Kumar V; Tyagi BK
J Trop Pediatr; 2014 Jun; 60(3):245-8. PubMed ID: 24343822
[TBL] [Abstract][Full Text] [Related]
10. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P
Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831
[TBL] [Abstract][Full Text] [Related]
11. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs.
De Rochars MB; Direny AN; Roberts JM; Addiss DG; Radday J; Beach MJ; Streit TG; Dardith D; Lafontant JG; Lammie PJ
Am J Trop Med Hyg; 2004 Oct; 71(4):466-70. PubMed ID: 15516644
[TBL] [Abstract][Full Text] [Related]
12. Comparison of methods for estimating drug coverage for filariasis elimination, Leogane Commune, Haiti.
Mathieu E; Deming M; Lammie PJ; McLaughlin SI; Beach MJ; Deodat DJ; Addiss DG
Trans R Soc Trop Med Hyg; 2003; 97(5):501-5. PubMed ID: 15307410
[TBL] [Abstract][Full Text] [Related]
13. Assessment of microfilaremia in 'hotspots' of four lymphatic filariasis endemic districts of Nepal during post-MDA surveillance.
Mehta PK; Maharjan M
PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011932. PubMed ID: 38295107
[TBL] [Abstract][Full Text] [Related]
14. How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?
Kura K; Stolk WA; Basáñez MG; Collyer BS; de Vlas SJ; Diggle PJ; Gass K; Graham M; Hollingsworth TD; King JD; Krentel A; Anderson RM; Coffeng LE
Clin Infect Dis; 2024 Apr; 78(Supplement_2):S93-S100. PubMed ID: 38662701
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.
Dubray CL; Sircar AD; Beau de Rochars VM; Bogus J; Direny AN; Ernest JR; Fayette CR; Goss CW; Hast M; O'Brian K; Pavilus GE; Sabin DF; Wiegand RE; Weil GJ; Lemoine JF
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008298. PubMed ID: 32511226
[TBL] [Abstract][Full Text] [Related]
16. The role of albendazole in programmes to eliminate lymphatic filariasis.
Ottesen EA; Ismail MM; Horton J
Parasitol Today; 1999 Sep; 15(9):382-6. PubMed ID: 10461168
[TBL] [Abstract][Full Text] [Related]
17. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
de Kraker ME; Stolk WA; van Oortmarssen GJ; Habbema JD
Trop Med Int Health; 2006 May; 11(5):718-28. PubMed ID: 16640625
[TBL] [Abstract][Full Text] [Related]
18. A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis.
El Setouhy M; Ramzy RM; Ahmed ES; Kandil AM; Hussain O; Farid HA; Helmy H; Weil GJ
Am J Trop Med Hyg; 2004 Feb; 70(2):191-6. PubMed ID: 14993632
[TBL] [Abstract][Full Text] [Related]
19. A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018.
Willis GA; Mayfield HJ; Kearns T; Naseri T; Thomsen R; Gass K; Sheridan S; Graves PM; Lau CL
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008854. PubMed ID: 33253148
[TBL] [Abstract][Full Text] [Related]
20. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
Nandha B; Krishnamoorthy K; Jambulingam P
Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
